Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised IgG1 kappa antibody against serum amyloid A and AL amyloid

EU orphan designation number: EU/3/13/1100   
Active ingredient: Humanised IgG1 kappa antibody against serum amyloid A and AL amyloid
Indication: Treatment of amyloid light-chain amyloidosis
Sponsor: Prothena Therapeutics Limited
Adelphi Plaza, Upper George's Street, Dun Laoghaire, Co. Dublin A96 T927, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/02/2013 Orphan designation EMA/OD/129/12 (2013)801 of 08/02/2013
26/03/2015 Change of name and/or address of sponsor
01/04/2016 Change of name and/or address of sponsor